Identification of CD49a+ CD8+ resident memory T cells in vitiligo-like lesions associated with nivolumab treatment for melanoma.

Nakashima, C; Ishida, Y; Nakagawa, K; Irie, H; Hirata, M; Kataoka, T; Otsuka, A; Kabashima, K

Nakashima, C; Ishida, Y; Nakagawa, K; Irie, H; Hirata, M; Kataoka, T; Otsuka, A; Kabashima, K.

Afiliação

Nakashima C; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ishida Y; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Nakagawa K; Department of Dermatology, Saiseikai Tondabayashi Hospital, Osaka, Japan.
Irie H; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hirata M; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kataoka T; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Otsuka A; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kabashima K; Translational Research Department for Skin and Brain Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.

J Eur Acad Dermatol Venereol ; 34(2): e79-e82, 2020 Feb.

Article em En | MEDLINE | ID: mdl-31571305

Assuntos

Antineoplásicos Imunológicos/uso terapêutico; Linfócitos T CD8-Positivos/imunologia; Memória Imunológica; Integrina alfa1/imunologia; Melanoma/tratamento farmacológico; Nivolumabe/uso terapêutico; Vitiligo/imunologia; Humanos; Melanoma/imunologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitiligo / Linfócitos T CD8-Positivos / Integrina alfa1 / Antineoplásicos Imunológicos / Nivolumabe / Memória Imunológica / Melanoma Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google